Australian REITS Stock News

ASX:EDV
ASX:EDVConsumer Retailing

A Look At Endeavour Group’s Valuation As Cost Cuts And Leadership Refresh Face Investor Scrutiny

Endeavour Group (ASX:EDV) has come under pressure after its shares touched a new 52 week low. Investors are questioning the execution of a three year, A$100 million cost reduction plan under new leadership. See our latest analysis for Endeavour Group. The latest bounce to A$3.09 comes after a year in which the stock’s share price return and three year total shareholder return have both been weak. This suggests recent cost cutting headlines and the upcoming investor day are being viewed...
ASX:LNW
ASX:LNWHospitality

Light & Wonder (ASX:LNW) Valuation After Q1 Revenue Growth But Softer Earnings

Earnings update and why Light & Wonder (ASX:LNW) is in focus Light & Wonder (ASX:LNW) has drawn fresh attention after reporting first quarter 2026 results, with revenue at US$790 million compared with US$774 million a year earlier, while net income and earnings per share came in lower. See our latest analysis for Light & Wonder. At a latest share price of A$114.58, the stock has gained 1-day and 7-day share price returns of 1.37% and 3.88% respectively, yet is down 26.55% year to date. The...
ASX:AUB
ASX:AUBInsurance

A Look At AUB Group's Valuation After Upgraded Guidance And Higher Interim Dividend

AUB Group (ASX:AUB) shares are in focus after the company reported strong first half FY26 underlying profit growth, upgraded its full year earnings guidance, and lifted its fully franked interim dividend. See our latest analysis for AUB Group. The A$25.30 share price moved 5.0% higher on the day and 5.2% over the past week, but the stock is still down 17.2% on a year to date share price basis. The 1 year total shareholder return has declined 25.1%, so the latest earnings and dividend update...
ASX:OBM
ASX:OBMMetals and Mining

How Ora Banda’s Reserve Upgrade and Plant Expansion Will Impact Ora Banda Mining (ASX:OBM) Investors

Ora Banda Mining has outlined an expansion plan to roughly double gold production over the next three years, including a 3.0‑million‑tonnes‑per‑annum processing plant at Davyhurst and development of the Waihi underground mine, supported by increased funding capacity. In parallel, the company has more than doubled its gold Ore Reserve base to underpin this growth, lifting total mineral resources to 3.57 million ounces and appointing GR Engineering Services as preferred contractor for the...
ASX:VLS
ASX:VLSPharmaceuticals

3 ASX Penny Stocks With Market Caps Under A$1B To Consider

The Australian market is poised for a potential rebound today, with futures indicating a possible one percent increase despite Wall Street's recent lackluster performance. Amidst these fluctuations, investors are increasingly turning their attention to penny stocks—smaller or newer companies that offer growth opportunities at lower price points. Although the term "penny stock" might seem outdated, these investments can still present valuable prospects when backed by robust financial health...
ASX:MIN
ASX:MINMetals and Mining

Is It Too Late To Consider Mineral Resources (ASX:MIN) After Strong 1 Year Rally?

Some investors may be wondering whether Mineral Resources at around A$65.74 is still priced attractively, or if most of the easy gains are already behind it. The stock has been volatile, with a return of 18.6% year to date, a 3.5% gain over the last 30 days, but a decline of 5.9% over the last week, while the 1 year return stands at 167.7%. Recent news coverage has focused on Mineral Resources in the context of lithium, iron ore and broader materials sector sentiment, which often shifts...
ASX:ALL
ASX:ALLHospitality

Aristocrat Leisure (ASX:ALL) Is Up 12.8% After Boosting Buyback And Dividend Payouts - What's Changed

Aristocrat Leisure recently reported half-year 2026 results showing sales of A$3,028.2 million and net income of A$805.5 million, alongside authorising an unfranked interim dividend of A$0.50 per share and expanding its on-market buyback to A$2.50 billions through to May 2027. These income and capital management decisions, combined with ongoing investment in AI and digital gaming through Aristocrat Interactive and NeoGames integration, highlight management’s focus on reshaping the business...
ASX:ASX
ASX:ASXCapital Markets

A Look At ASX (ASX:ASX) Valuation As New CEO Anthony Attia Prepares To Take The Helm

ASX (ASX:ASX) has announced Anthony Attia as its next Chief Executive Officer and Managing Director, effective 1 September 2026. This marks a leadership transition that could influence how investors think about the exchange stock. See our latest analysis for ASX. The leadership announcement comes at a time when momentum in the stock has picked up, with a 1-day share price return of 1.80% and a year-to-date share price return of 15.33%, even though the 1-year total shareholder return has...
ASX:BHP
ASX:BHPMetals and Mining

Assessing BHP Group’s Valuation As New CEO Signals Shift To Smaller Deals And Organic Growth

BHP Group (ASX:BHP) is back in focus after comments from incoming CEO Brandon Craig about prioritising smaller bolt-on deals and organic growth, just as weaker commodity prices and tax concerns pressure sentiment. See our latest analysis for BHP Group. Recent volatility around the incoming CEO’s comments and softer commodity prices comes after a strong run, with the latest A$58.7 share price sitting alongside a 28.3% year to date share price return and a 58.4% one year total shareholder...
ASX:ALQ
ASX:ALQProfessional Services

ALS (ASX:ALQ) Margin Improvement Challenges Bearish Narratives In FY 2026 Results

ALS (ASX:ALQ) has just posted its FY 2026 results, with second half revenue of A$1.66 billion, basic EPS of A$0.35 and net income of A$177.0 million framing a solid finish to the year. The company has seen revenue move from A$1.54 billion and basic EPS of A$0.27 in the second half of FY 2025 to A$1.66 billion and A$0.35 in the latest half, while trailing 12 month EPS and net income have also risen from A$0.53 and A$256.2 million to A$0.63 and A$318.7 million respectively, setting up a...
ASX:ELV
ASX:ELVMetals and Mining

Assessing Elevra Lithium (ASX:ELV) Valuation After Capital Raise And North American Lithium Expansion Update

Elevra Lithium (ASX:ELV) has moved back into focus after completing a fully underwritten A$275 million equity raise and releasing an updated Scoping Study for its North American Lithium expansion in Quebec. See our latest analysis for Elevra Lithium. These funding and project updates come after a sharp pullback, with a 7 day share price return of down 16.96% following a strong 90 day share price return of 44.8% and a very large 1 year total shareholder return. This suggests momentum has...
ASX:BXB
ASX:BXBCommercial Services

Brambles (ASX:BXB) Is Down 19.0% After US Bottlenecks Hit Guidance And A US$400m Buyback Launch

In May 2026, Brambles Limited (ASX:BXB) announced a new on-market share repurchase program of up to 134,664,225 shares (10% of its 1,346,642,250 shares on issue) for US$400 million, to be executed by June 30, 2027, aiming to improve capital efficiency and shareholder value. On the same day, Brambles cut its FY26 sales and earnings guidance due to US pallet repair capacity constraints, highlighting how labour shortages and higher quality standards in its subcontractor network are directly...
ASX:MQG
ASX:MQGCapital Markets

Macquarie Group (ASX:MQG) Valuation Check After Recent Share Price Momentum

Macquarie Group (ASX:MQG) has come into focus after recent share price moves, with the stock last closing at A$240.98. Investors are assessing this level in relation to the group’s diversified global earnings profile. See our latest analysis for Macquarie Group. Recent trading has been relatively upbeat, with a 1-day share price return of 1.87% and a 7-day share price return of 2.90% adding to a 90-day share price return of 9.74%. Over longer horizons, the 1-year total shareholder return of...
ASX:TNE
ASX:TNESoftware

Technology One (ASX:TNE) Net Margin Compression Tests Premium Growth Narrative

Technology One (ASX:TNE) has just posted its H1 2026 scorecard, with trailing twelve month revenue at A$631.2 million and basic EPS at A$0.433, set against a current share price of A$27.80. The company has seen revenue move from A$551.7 million with EPS of A$0.407 in the TTM period to H1 2025, to A$598.5 million and EPS of A$0.421 in the TTM to H2 2025, and then to A$631.2 million and EPS of A$0.433 in the latest TTM window. This gives investors a clear view of how the top and bottom lines...
ASX:ELD
ASX:ELDFood

Do Elders' (ASX:ELD) Steady EPS Mask Shifting Drivers Behind Its Profit Recovery?

Elders Limited recently reported past half-year results to 31 March 2026, with sales rising to A$1,767.68 million and net income to A$39.45 million, while basic earnings per share from continuing operations edged up to A$0.166. Despite higher sales and net income, overall basic earnings per share held steady at A$0.188, suggesting that profit growth was broadly matched by changes in the share base or one-off factors. We’ll now explore how Elders’ higher half-year sales and net income figures...
ASX:PDN
ASX:PDNOil and Gas

Paladin Energy (ASX:PDN) Is Down 16.3% After Returning To Quarterly Profitability Is The Bull Case Changed?

In May 2026, Paladin Energy Ltd reported its third-quarter and nine-month results to March 31, 2026, showing sales rising to US$70.7 million for the quarter and US$209.05 million for the nine months, with net income turning positive at US$0.779 million and US$1.65 million respectively after losses a year earlier. The move from loss to a small profit, with basic earnings per share improving from a loss of US$0.064 to earnings of US$0.002 for the quarter, highlights how even modest...
ASX:PME
ASX:PMEHealthcare Services

Pro Medicus ASX PME Valuation Check After New A$90 Million Beth Israel Lahey Health Cloud Imaging Deal

Pro Medicus (ASX:PME) has signed a seven year, A$90 million transaction-based deal with Beth Israel Lahey Health to deploy its Visage 7 cloud imaging platform across 14 US hospitals, underscoring its US healthcare expansion. See our latest analysis for Pro Medicus. The A$90 million Beth Israel Lahey Health deal lands at a time when the stock has climbed 2.8% over the past day but is down 15.6% on a 30 day share price return and 43.6% year to date. The three year total shareholder return of...